Why is Hikal Ltd falling/rising?

Recent Price Movement and Market Context

Hikal Ltd’s share price has been under pressure, closing just 3.23% above its 52-week low of ₹217.35. The stock reversed gains after two consecutive days of upward movement, signalling renewed selling interest. It has also underperformed its sector by 1.24% on the latest trading day, indicating relative weakness within its industry peers. Notably, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend in technical analysis.

Investor participation has shown some increase, with delivery volumes on 02 Jan rising by 180.47% compared to the five-day average, yet this heightened activity has not translated into price strength. Liquidity remains adequate for moderate trade sizes, but the overall sentiment appears cautious.

Long-Term Underperformance and Financial Weakness

Over the past year, Hikal Ltd’s stock has delivered a negative return of 43.54%, starkly contrasting with the Sensex’s positive 7.85% gain over the same period. The underperformance extends over three years, with the stock down 44.99% while the Sensex has risen by 41.57%. Even over five years, the stock’s 26.36% gain lags significantly behind the benchmark’s 76.39% appreciation. This persistent lag highlights structural challenges facing the company.

Fundamentally, the company’s operating profits have declined at a compounded annual growth rate (CAGR) of -16.24% over the last five years, signalling weakening core business performance. The return on equity (ROE) averages a modest 8.00%, indicating limited profitability relative to shareholders’ funds. Furthermore, the company’s ability to service debt is constrained, with a high Debt to EBITDA ratio of 2.51 times, raising concerns about financial leverage and risk.

Recent Quarterly Results and Profitability Concerns

Hikal Ltd’s recent quarterly results have been particularly disappointing. The company reported net sales of ₹318.50 crores, down 30.5% compared to the previous four-quarter average. More alarmingly, the profit after tax (PAT) plunged by 320.5%, resulting in a loss of ₹34.90 crores. This marks the second consecutive quarter of negative earnings, underscoring the severity of the company’s operational challenges. The return on capital employed (ROCE) for the half-year period stands at a low 4.44%, further reflecting subpar capital efficiency.

These weak results have contributed to the stock’s sharp decline and negative investor sentiment, as reflected in the substantial drop in earnings per share (EPS) by over 320% in the recent period. The company’s valuation metrics, while appearing attractive with an enterprise value to capital employed ratio of 1.8, are overshadowed by the deteriorating profitability and growth outlook.

Summary and Investor Takeaway

In summary, Hikal Ltd’s share price decline is primarily driven by a combination of weak financial performance, including sharply falling profits and negative quarterly results, alongside sustained underperformance relative to market benchmarks. The company’s low profitability, high leverage, and poor growth trajectory have weighed heavily on investor confidence. Despite trading at a discount to peers, the fundamental challenges have overshadowed any valuation appeal.

Investors should be cautious given the company’s recent earnings volatility and the absence of clear signs of recovery. The stock’s technical indicators and relative weakness within its sector further reinforce a bearish outlook in the near term. Those considering exposure to Hikal Ltd may wish to evaluate alternative opportunities within the pharmaceuticals and biotechnology sectors that demonstrate stronger fundamentals and more consistent growth prospects.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →